Companion Diagnostics Market 2025 to 2035
Companion Diagnostics Market 2025 to 2035
Companion Diagnostics Market (By Indication: Cancer, Neurological Disorders, Cardiovascular Diseases, Infectious Diseases, Other Indications; By Product & Service: Assays, Kits & Reagents, Software & Services; By Technology: Polymerase Chain Reaction, Next-generation Sequencing, In Situ Hybridization, Immunohistochemistry, Other; By End-User: Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, Other End Users) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034
Customisation Request
Revenue, 2025
USD 9.97 Bn
Forecast Year, 2035
USD 31.46 Bn
CAGR, 2025 - 2035
12.18%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global companion diagnostics market is poised for significant growth, expanding from USD 9.97 billion in 2025 to an estimated USD 31.46 billion by 2035, at a robust CAGR of 12.18%, driven by precision medicine adoption and biomarker advancements.
Companion Diagnostics Market Size Analysis
Companion Diagnostics Market Size By Indication 2025 to 2035 (USD Billion)
| Indication | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cancer | 1.59 | 1.87 | 2.20 | 2.39 | 3.00 | 3.48 | 3.97 | 4.50 | 5.09 | 5.52 | 6.18 |
| Neurological Disorders | 1.49 | 1.55 | 1.93 | 2.08 | 2.36 | 2.61 | 2.77 | 3.24 | 3.50 | 4.29 | 4.54 |
| Cardiovascular Diseases | 5.06 | 5.55 | 6.05 | 6.83 | 7.45 | 8.16 | 9.22 | 10.07 | 10.91 | 12.10 | 13.31 |
| Infectious Diseases | 0.37 | 0.41 | 0.41 | 0.48 | 0.39 | 0.65 | 0.76 | 0.89 | 1.14 | 1.37 | 1.96 |
| Other Indications | 1.47 | 1.81 | 1.95 | 2.29 | 2.58 | 2.81 | 3.15 | 3.59 | 4.36 | 4.78 | 5.47 |
Companion Diagnostics Market Size By Product & Service 2025 to 2035 (USD Billion)
| Product & Service | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assays, Kits & Reagents | 8.91 | 9.85 | 11.24 | 12.54 | 14.04 | 15.77 | 17.50 | 19.71 | 22.21 | 24.86 | 27.09 |
| Software & Services | 1.06 | 1.33 | 1.31 | 1.53 | 1.75 | 1.94 | 2.37 | 2.58 | 2.79 | 3.19 | 4.38 |
Companion Diagnostics Market Size By Technology 2025 to 2035 (USD Billion)
| Technology | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Polymerase Chain Reaction | 0.69 | 0.91 | 0.89 | 0.87 | 0.88 | 1.31 | 1.68 | 1.43 | 1.77 | 2.05 | 2.49 |
| Next-generation Sequencing | 0.27 | 0.37 | 0.39 | 0.52 | 0.73 | 0.66 | 0.55 | 0.50 | 0.49 | 0.46 | 0.39 |
| In Situ Hybridization | 2.01 | 2.33 | 2.73 | 3.02 | 3.35 | 3.54 | 4.13 | 4.57 | 5.04 | 5.75 | 5.84 |
| Immunohistochemistry | 2.49 | 2.71 | 3.09 | 3.52 | 3.77 | 4.13 | 4.72 | 5.71 | 6.31 | 6.80 | 7.99 |
| Other | 4.51 | 4.87 | 5.44 | 6.15 | 7.05 | 8.07 | 8.79 | 10.08 | 11.39 | 12.99 | 14.75 |
Companion Diagnostics Market Size By Therapeutic Area 2025 to 2035 (USD Billion)
| Therapeutic Area | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 3.89 | 4.39 | 5.09 | 5.66 | 6.45 | 7.53 | 8.35 | 9.46 | 10.62 | 11.57 | 13.02 |
| Neurology | 0.25 | 0.28 | 0.45 | 0.45 | 0.41 | 0.21 | 0.37 | 0.23 | 0.57 | 0.86 | 0.79 |
| Infectious Diseases | 4.34 | 4.95 | 5.31 | 5.91 | 6.57 | 7.53 | 8.35 | 9.54 | 10.60 | 12.24 | 14.08 |
| Others | 1.49 | 1.57 | 1.70 | 2.05 | 2.37 | 2.44 | 2.80 | 3.06 | 3.21 | 3.39 | 3.58 |
Companion Diagnostics Market Size By End-User 2025 to 2035 (USD Billion)
| End-User | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceutical & Biopharmaceutical Companies | 0.35 | 0.50 | 0.67 | 0.60 | 0.46 | 0.64 | 0.83 | 0.86 | 0.55 | 0.67 | 0.31 |
| Reference Laboratories | 2.37 | 2.69 | 3.11 | 3.81 | 4.26 | 4.86 | 5.32 | 6.13 | 7.15 | 7.95 | 8.83 |
| Contract Research Organizations | 6.69 | 7.43 | 8.01 | 8.83 | 10.05 | 10.98 | 12.02 | 13.72 | 15.50 | 17.21 | 19.44 |
| Other End Users | 0.57 | 0.56 | 0.75 | 0.83 | 1.02 | 1.23 | 1.70 | 1.59 | 1.80 | 2.22 | 2.87 |
Companion Diagnostics Market Size By Region 2025 to 2035 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.75 | 0.84 | 1.01 | 1.15 | 1.30 | 1.21 | 1.45 | 1.82 | 2.41 | 2.61 | 2.80 |
| Europe | 1.21 | 1.20 | 1.32 | 1.60 | 1.63 | 1.71 | 1.47 | 1.67 | 1.89 | 1.78 | 2.31 |
| Asia-Pacific | 2.60 | 2.94 | 3.36 | 3.70 | 4.12 | 4.96 | 5.49 | 6.29 | 6.66 | 7.27 | 8.35 |
| Latin America | 3.25 | 3.82 | 4.22 | 4.44 | 4.85 | 5.50 | 6.56 | 7.23 | 8.00 | 9.50 | 10.27 |
| Middle East & Africa (MEA) | 2.16 | 2.39 | 2.64 | 3.19 | 3.89 | 4.33 | 4.89 | 5.28 | 6.05 | 6.88 | 7.73 |
Companion Diagnostics Market Size to Reach USD 31.46 Billion by 2035
The global companion diagnostics market size was estimated at USD 9.97 billion in 2025 and is projected to be worth around USD 31.46 billion by 2035,with a CAGR of 12.18%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
